Issuer Client Profile

Matinas BioPharma Holdings, Inc. (MTNB)

Matinas BioPharma, a clinical-stage biopharmaceutical company, is transforming the way potent medicines are delivered and administered to provide physicians and patients with more tolerable, safer, effective and powerful therapeutic options in the battle against the growing “superbug” antimicrobial-resistant global public health threat.